AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $551,851 | -19.1% | 7,896 | -16.8% | 0.01% | -28.6% |
| Q2 2023 | $681,808 | +12.8% | 9,488 | -3.2% | 0.01% | 0.0% |
| Q1 2023 | $604,587 | -3.0% | 9,802 | +21.3% | 0.01% | +16.7% |
| Q4 2022 | $623,442 | -99.9% | 8,083 | -60.4% | 0.01% | +20.0% |
| Q3 2022 | $456,456,000 | +83961.9% | 20,434 | +44.2% | 0.01% | -16.7% |
| Q2 2022 | $543,000 | +36.8% | 14,169 | +47.7% | 0.01% | +50.0% |
| Q1 2022 | $397,000 | +68.2% | 9,595 | +53.4% | 0.00% | +100.0% |
| Q4 2021 | $236,000 | +12.4% | 6,254 | -2.0% | 0.00% | 0.0% |
| Q3 2021 | $210,000 | -44.4% | 6,384 | +14.0% | 0.00% | -50.0% |
| Q2 2021 | $378,000 | +68.0% | 5,600 | +41.0% | 0.00% | +33.3% |
| Q1 2021 | $225,000 | – | 3,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |